5 completed, 2 unknown, 1 recruiting, 1 terminated. 10 Phase 2, 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Vaccination: new trials by email Literature Review of Vaccination trials Research Report on Vaccination
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older Vaccination with rBCG-N-RSV, Vaccination with conventional BCG (BCG-WT) - Respiratory Syncytial Virus Infection Prevention, Tuberculosis Prevention | Phase 2 | Recruiting | Biothervax SpA | 200 | 2026-09-14 | 2026-09-15 |
| Community-based Behavioral Intervention to Increase Vaccination Using MOST Health education on COVID and flu vaccination, Nurse-led shared decision-making, Text messages - COVID 19, Influenza | Phase 2 | Withdrawn | New York University | 2025-04-01 | 2025-04-29 | |
| A Study of MG1111 in Healthy Children Varicella Vaccine - Healthy Children | Phase 2 / Phase 3 | Completed | Green Cross Corporation | 814 | 2016-11-26 | 2021-05-14 |
| Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease Vaccination with the combined vaccine (Prevenar13 ®), Vaccination with the polysaccharide vaccine (Pneumo 23 ®) - Invasive Pneumococcal Infections, Sickle Cells Disease | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 116 | 2013-09-16 | 2022-09-09 |
| A Fmri Study on the Effects of a Conjugate Vaccine and Placebo on CNS Activation and Behavior Following a Nicotine Challenge vaccination with Nicvax - Nicotine Dependency, Smoking | Phase 1 / Phase 2 | Completed | Maastricht University Medical Center | 38 | 2011-02-01 | 2013-03-04 |
| Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) vaccination - Esophageal Cancer | Phase 2 | Unknown | University of Yamanashi | 60 | 2010-04-01 | 2010-12-28 |
| Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients Vaccination with VZV vaccine - Liver Disease, Immunosuppression | Phase 2 / Phase 3 | Unknown | University Hospital, Geneva | 80 | 2007-06-01 | 2020-09-18 |
| Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART LC002 standard vaccination, LC002 high-dose vaccination, LC002 placebo vaccination - HIV Infections | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 28 | 2006-01-01 | 2021-11-04 |
| Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy Vaccination - Influenza | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 200 | 2005-10-01 | 2006-11-07 |
| Dendritic Cells (DC) Vaccine for Metastatic Melanoma Vaccination - Metastatic Melanoma | Phase 2 | Terminated | John Kirkwood | 16 | 2002-10-01 | 2017-08-16 |
Influenza, Human (2) · Anemia, Sickle Cell (1) · COVID-19 (1) · Chickenpox (1) · Esophageal Neoplasms (1) · HIV Infections (1) · Liver Diseases (1) · Melanoma (1) · Smoking (1) · Tuberculosis (1)
Assistance Publique - Hôpitaux de Paris (1) · Biothervax SpA (1) · Green Cross Corporation (1) · Hadassah Medical Organization (1) · John Kirkwood (1) · Maastricht University Medical Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · New York University (1) · University Hospital, Geneva (1) · University of Yamanashi (1)
United States (2) · France (1) · Greece (1) · Israel (1) · Japan (1) · Netherlands (1) · South Korea (1) · Switzerland (1)
Arie Ben Yehuda, M.D. (1) · Benigno Rodriguez, MD (1) · John M Kirkwood, MD (1) · Klara M Posfay-Barbe, MD, MS (1) · Koji Kono, PhD, MD (1)
2023 (1), P01CA073743 (1)